<unk>  fumarate has been approved for the treatment of allergic rhinitis and chronic urticaria in adults and children over 12 years. It is available as round, light salmon coloured tablets containing 10 mg of<unk>  (as fumarate) to be administered orally, once a day. The efficacy of<unk>  as treatment for allergic rhinitis (AR) and chronic idiopathic urticaria (CIU) has been investigated in adults and adolescents (aged over 12 years) in several controlled studies, showing a rapid onset of action and a good safety profile even in prolonged treatment periods of a year.
Rupatadine
Loratadine
Olopatadine
Quifenadine
Desloratadine
Rimantadine
Roxadustat
Mitapivat